Adoptive immunotherapy using lymphokine-activated killer cells.
Fowler
J E
JE
Division of Urology, University of Illinois College of Medicine, Chicago.
D001804:Blood Transfusion, Autologous; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000556:secondary / Q000628:therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000276:immunology* / Q000494:pharmacology; D007680:Kidney Neoplasms / Q000276:immunology / Q000556:secondary / Q000628:therapy; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology / Q000637:transplantation*; D007937:Leukapheresis; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2